Brief: Windtree Therapeutics Files For $27.2 Mln Stock Sale
28/10/2024 21:28
Oct 28 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS INC - FILES PROSPECTUS SUPPLEMENT
FOR
$27.2 MILLION STOCK SALE
* WINDTREE THERAPEUTICS INC - MAY SELL & ISSUE SHARES TO
SEVEN
KNOTS FROM TIME TO TIME UNDER EQUITY LINE
Source text: ID:n0001437749-24-032316
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study